Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment

Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment

US Patent 9375488 · Granted Jun 28, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radioconjugates targeting CD33 in the treatment of sarcomas2025
Radioconjugates directed to MHC-complexed antigens in cancer2025
Anti-CD45-based conditioning methods and uses thereof in conjunction with gene-e2024
Anti-PD-L1-anti-TIM-3 bispecific antibodies2022
Checkpoint inhibitor bispecific antibodies2021
Checkpoint inhibitor bispecific antibodies2021
Anti-canine platelet derived growth factor receptor alpha antibody2020
Inhibition of SGK1 in the treatment of heart conditions2019
Anti-PD-L1-anti-TIM-3 bispecific antibodies2019
PD-L1 antibodies2019
Cysteine engineered antibodies and conjugates2018
Inhibition of SGK1 in the treatment of heart conditions2018